VEGF has immunosuppressive effects by e.g. recruiting tumor associated M2 type macrophages [65] and the increase in macrophages following antiangiogenic treatment has been proposed to play a critical role in evasion mechanisms of GBM and its therapy resistance [66, 67]. The gene discussed is VEGFA; the disease is glioblastoma.